ALTACE
- Product NDC
- 61570-111
- 11-digit product format
- 615700111
- Labeler code
- 61570
- Product ID
- 61570-111_7c58ba31-97ac-4b94-93c7-d6c9868df832
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ramipril
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA019901
- Marketing category
- NDA
- Marketing start
- 1991-01-28
- Marketing end
- 0000-00-00
- Substance
- RAMIPRIL
- Active strength
- 3 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61570-111 | ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 27 | Legacy NDC | 20250109_0fc34cd8-86e6-4034-73bd-4263a68ba046.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61570-111-01 | 61570011101 | 100 CAPSULE in 1 BOTTLE (61570-111-01) | 100 capsule | 1991-01-28 | 0000-00-00 | No | No | Current |